214 related articles for article (PubMed ID: 32082998)
1. Meta-Analysis of Hematological Biomarkers as Reliable Indicators of Soft Tissue Sarcoma Prognosis.
Li LQ; Bai ZH; Zhang LH; Zhang Y; Lu XC; Zhang Y; Liu YK; Wen J; Li JZ
Front Oncol; 2020; 10():30. PubMed ID: 32082998
[No Abstract] [Full Text] [Related]
2. Prognostic value of neutrophil/lymphocyte, platelet/lymphocyte, lymphocyte/monocyte ratios and Glasgow prognostic score in osteosarcoma: A meta-analysis.
Peng LP; Li J; Li XF
World J Clin Cases; 2022 Mar; 10(7):2194-2205. PubMed ID: 35321179
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Significance of Hematological Markers for Patients with Nasopharyngeal Carcinoma: A Meta-analysis.
Yang S; Zhao K; Ding X; Jiang H; Lu H
J Cancer; 2019; 10(11):2568-2577. PubMed ID: 31258763
[No Abstract] [Full Text] [Related]
4. Clinical implications of six inflammatory biomarkers as prognostic indicators in Ewing sarcoma.
Li YJ; Yang X; Zhang WB; Yi C; Wang F; Li P
Cancer Manag Res; 2017; 9():443-451. PubMed ID: 29033609
[TBL] [Abstract][Full Text] [Related]
5. Systemic Inflammatory Markers for Predicting Overall Survival in Patients with Osteosarcoma: A Systematic Review and Meta-Analysis.
Song X; Zhang H; Yin F; Guo P; Yang X; Liu J; Han Y; Ren Z
Mediators Inflamm; 2021; 2021():3456629. PubMed ID: 34720749
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of elevated pretreatment systemic inflammatory markers for patients with prostate cancer: a meta-analysis.
Peng H; Luo X
Cancer Cell Int; 2019; 19():70. PubMed ID: 30962764
[TBL] [Abstract][Full Text] [Related]
7. Inflammation and nutrition-based biomarkers in the prognosis of oesophageal cancer: a systematic review and meta-analysis.
Jiang Y; Xu D; Song H; Qiu B; Tian D; Li Z; Ji Y; Wang J
BMJ Open; 2021 Sep; 11(9):e048324. PubMed ID: 34593492
[TBL] [Abstract][Full Text] [Related]
8. Preoperative platelet-lymphocyte ratio is superior to neutrophil-lymphocyte ratio as a prognostic factor for soft-tissue sarcoma.
Que Y; Qiu H; Li Y; Chen Y; Xiao W; Zhou Z; Zhang X
BMC Cancer; 2015 Oct; 15():648. PubMed ID: 26432433
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Value of Pretreated Blood Inflammatory Markers in Patients with Bone Sarcoma: A Meta-Analysis.
Jiang M; Ma S; Hua Z; Zhao Z; Gao S
Dis Markers; 2021; 2021():8839512. PubMed ID: 33897913
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.
Li Y; Liu X; Zhang J; Yao W
Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589
[TBL] [Abstract][Full Text] [Related]
11. Preoperative Neutrophil Lymphocyte Ratio Can Be Used as a Predictor of Prognosis in Patients With Adenocarcinoma of the Esophagogastric Junction: A Systematic Review and Meta Analysis.
Liu XB; Gao ZY; Zhang QH; Pandey S; Gao B; Yang F; Tong Q; Li SB
Front Oncol; 2020; 10():178. PubMed ID: 32154173
[No Abstract] [Full Text] [Related]
12. Prognostic value of pre-operative inflammatory response biomarkers in gastric cancer patients and the construction of a predictive model.
Deng Q; He B; Liu X; Yue J; Ying H; Pan Y; Sun H; Chen J; Wang F; Gao T; Zhang L; Wang S
J Transl Med; 2015 Feb; 13():66. PubMed ID: 25885254
[TBL] [Abstract][Full Text] [Related]
13. The clinical use of the platelet/lymphocyte ratio and lymphocyte/monocyte ratio as prognostic predictors in colorectal cancer: a meta-analysis.
Guo YH; Sun HF; Zhang YB; Liao ZJ; Zhao L; Cui J; Wu T; Lu JR; Nan KJ; Wang SH
Oncotarget; 2017 Mar; 8(12):20011-20024. PubMed ID: 28212553
[TBL] [Abstract][Full Text] [Related]
14. Are the Derived Indexes of Peripheral Whole Blood Cell Counts (NLR, PLR, LMR/MLR) Clinically Significant Prognostic Biomarkers in Multiple Myeloma? A Systematic Review And Meta-Analysis.
Zhang X; Duan J; Wen Z; Xiong H; Chen X; Liu Y; Liao K; Huang C
Front Oncol; 2021; 11():766672. PubMed ID: 34888244
[TBL] [Abstract][Full Text] [Related]
15. Pretreatment hematological markers predict clinical outcome in cancer patients receiving immune checkpoint inhibitors: A meta-analysis.
Tan Q; Liu S; Liang C; Han X; Shi Y
Thorac Cancer; 2018 Oct; 9(10):1220-1230. PubMed ID: 30151899
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of inflammation-related biomarkers in patients with gastroenteropancreatic neuroendocrine neoplasms: A systematic review and meta-analysis.
Cui LJ; Yu FH; Cheng ZX; Su F; Chen YY; Tan HY
J Neuroendocrinol; 2024 Apr; 36(4):e13381. PubMed ID: 38468159
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil to Lymphocyte Ratio and Platelet to Lymphocyte Ratio as Prognostic Predictors for Hepatocellular Carcinoma Patients with Various Treatments: a Meta-Analysis and Systematic Review.
Zheng J; Cai J; Li H; Zeng K; He L; Fu H; Zhang J; Chen L; Yao J; Zhang Y; Yang Y
Cell Physiol Biochem; 2017; 44(3):967-981. PubMed ID: 29179180
[TBL] [Abstract][Full Text] [Related]
18. Prognostic impact of the combination of neutrophil-to-lymphocyte ratio and Glasgow prognostic score in colorectal cancer: a retrospective cohort study.
Inamoto S; Kawada K; Okamura R; Hida K; Sakai Y
Int J Colorectal Dis; 2019 Jul; 34(7):1303-1315. PubMed ID: 31177316
[TBL] [Abstract][Full Text] [Related]
19. Combined Use of the Neutrophil-Lymphocyte and Platelet-Lymphocyte Ratios as a Prognostic Predictor in Patients with Operable Soft Tissue Sarcoma.
Liang Y; Wang W; Li J; Guan Y; Que Y; Xiao W; Zhang X; Zhou Z
J Cancer; 2018; 9(12):2132-2139. PubMed ID: 29937932
[No Abstract] [Full Text] [Related]
20. The value of C-reactive protein as an independent prognostic indicator for disease-specific survival in patients with soft tissue sarcoma: A meta-analysis.
Wang X; Liu S; Zhao X; Fang E; Zhao X
PLoS One; 2019; 14(7):e0219215. PubMed ID: 31260491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
